March 03, 2015 6:54 AM ET


Company Overview of Vicept Therapeutics Incorporated

Company Overview

Vicept Therapeutics, Inc. is a biopharmaceutical company that develops products for dermatology markets. Its products include V-101 is a prescription topical formulation for the treatment of the erythema of rosacea; V-102, an actinic purpura solution; and V-103, a peri-procedural bruising solution. The company also engages in the development of topical agents for the treatment and prevention of various medical and cosmetic indications, including bruising of the skin. The company was founded in 2009 and is based in Malvern, Pennsylvania. As of July 22, 2011, Vicept Therapeutics, Inc. operates as a subsidiary of Allergan Inc.

101 Lindenwood Drive

Suite 430

Malvern, PA 19355

United States

Founded in 2009





Key Executives for Vicept Therapeutics Incorporated

Co-Founder and Chief Operating officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Adenios, Inc. United States
Melanovus Oncology, Inc. United States
Mesoblast, Inc. United States
Kineta Holdings II, LLC United States
TheraVasc, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Vicept Therapeutics Incorporated, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at